A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

Eli Lilly says its GLP-1 drug in pill form is as safe and effective as Ozempic and other mega-popular injectable drugs for weight loss and lowering blood sugar. The company announ ...

Lilly is expected to announce Phase 3 trial results for its pill orforglipron any day now. BMO Capital Markets analyst Evan Seigerman said Pfizer's discontinuation of its GLP-1 pill sends the ...

The small molecule “pill penalty” has particularly exacerbated R&D funding of therapies with a high exposure to the Medicare-aged population. Experts have warned that by creating a shorter ...